Balance Sheet Details

Balance sheet details were as follows:

Cash and cash equivalents



	As of
	April 30, 2019		October 31, 2018
	In millions
Cash and cash equivalents	$	3,585	$	4,880
Restricted cash⁽¹⁾	204		204
Cash, cash equivalents and restricted cash⁽²⁾	$	3,789	$	5,084

(1) Restricted cash was included in Other current assets in the Condensed Consolidated Balance Sheets.

(2) The beginning and ending balances of Cash, cash equivalents and restricted cash are disclosed in the Condensed Consolidated Statements of Cash Flows.

Inventory



	As of
	April 30, 2019		October 31, 2018
	In millions
Finished goods	$	1,222	$	1,274
Purchased parts and fabricated assemblies	960		1,173
Total	$	2,182	$	2,447

For the six months ended April 30, 2019, the decrease in inventory was due primarily to slower inventory replenishment as a result of improved market supply availability for key commodities.

Other Current Assets



	As of
	April 30, 2019		October 31, 2018
	In millions
Value-added tax receivables	$	633	$	811
Short-term tax receivables and prepaid taxes	264		535
Manufacturer and other receivables	886		1,141
Prepaid and other current assets	853		793
Total	$	2,636	$	3,280

For the six months ended April 30, 2019, the decrease in Other current assets was due primarily to a decrease in short-term tax receivables and prepaid taxes following the adoption of the new accounting standard related to income taxes in the first quarter of fiscal 2019, a decrease in manufacturer and other receivables as a result of lower receivables from contract manufacturers and a decrease in value-added tax receivables.

Property, Plant and Equipment



	As of
	April 30, 2019			October 31, 2018
	In millions
Land	$	293		$	294
Buildings and leasehold improvements	2,138			2,103
Machinery and equipment, including equipment held for lease	9,578			9,419
	12,009			11,816
Accumulated depreciation	(5,871		)	(5,678		)
Total	$	6,138		$	6,138

Notes Payable and Short-Term Borrowings



	As of
	April 30, 2019		October 31, 2018
	In millions
Current portion of long-term debt	$	1,186	$	1,196
FS commercial paper	551		392
Notes payable to banks, lines of credit and other⁽¹⁾	377		417
Total	$	2,114	$	2,005


(1)	As of April 30, 2019 and October 31, 2018, notes payable to banks, lines of credit and other includes $316 million and $361 million, respectively, of borrowing associated with FS and its subsidiaries.

Warranties

The Company's aggregate product warranty liability as of April 30, 2019, and changes during the six months then ended were as follows:



	Six Months Ended April 30, 2019
	In millions
Balance at beginning of period	$	430
Accruals for warranties issued	117
Adjustments related to pre-existing warranties	(4		)
Settlements made	(143		)
Balance at end of period	$	400

Contract balances

The Company’s contract balances consist of contract assets, contract liabilities, and costs to obtain a contract with a customer.

Contract Assets

A summary of accounts receivable, net, including unbilled receivables was as follows:



	As of
	April 30, 2019			October 31, 2018
	In millions
Accounts receivable, net
Accounts receivable	$	2,992		$	3,117
Unbilled receivables	184			185
Allowance for doubtful accounts	(33		)	(39		)
Total	$	3,143		$	3,263

Contract Liabilities

Contract liabilities consist of deferred revenue. The aggregate balances of current and non-current deferred revenue was $5.8 billion as of April 30, 2019 and October 31, 2018, which included $101 million and $82 million of deferred revenue related to FS, respectively. During the six months ended April 30, 2019, approximately $3.5 billion of deferred revenue was recognized as revenue.

Remaining Performance Obligations

Revenue allocated to remaining performance obligations represents contract work that has not yet been performed and does not include contracts where the customer is not committed. Remaining performance obligations estimates are subject to change and are affected by several factors, including contract terminations, changes in the scope of contracts, adjustments for revenue that has not materialized and adjustments for currency.

Remaining performance obligations consist of deferred revenue. As of April 30, 2019, the aggregate amount of remaining performance obligations was $5.8 billion. The Company expects to recognize approximately 43% of this amount as revenue over the remaining fiscal year.

Costs to Obtain a Contract

As of April 30, 2019, the current and non-current portions of the capitalized costs to obtain a contract were $43 million and $66 million, which were included in Other current assets and Long-term financing receivables and other assets, respectively, in the Condensed Consolidated Balance Sheet. During the three and six months ended April 30, 2019, the Company amortized $12 million and $22 million of the capitalized costs to obtain a contract, respectively.